NCT03201562View on ClinicalTrials.gov

A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 30, 2017

Primary Completion Date

May 20, 2018

Study Completion Date

May 20, 2018

Conditions
Presbyopia
Interventions
DRUG

Aceclidine+tropicamide combination

Ophthalmic Solution

DRUG

Aceclidine

Ophthalmic Solution

DRUG

Vehicle

Ophthalmic Solution

Trial Locations (1)

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

LENZ Therapeutics, Inc

OTHER

NCT03201562 - A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia | Biotech Hunter | Biotech Hunter